Stem Cells Live: Update from ACT: AMD clinical trial progress and future directions

  A brief but informative presentation from Mathew Vincent, Advanced cell technologies (ACT) served to remind us all that their clinical trial of an embryonic stem cell based therapy for age-related macular degeneration (AMD) is ongoing and beginning to generate more long term clinical data points.   A total of 34 patients with AMD or Stargardt’s disease have been treated …